论文信息 - Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma - 字舞流文

Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma

D. Schadendorf | R. Dummer | O. Michielin | H. Schmid | S. Micaletto | F. Campigotto | M. Nägeli | A. Pedroncelli | Simone M. Goldinger | U. Kriemler-Krahn